A virilizing Leydig cell tumor of the ovary associated with stromal hyperplasia under gonadotropin control

[1]  B. Slotman,et al.  Ovarian tumors with endocrine manifestations. , 1997, Current therapy in endocrinology and metabolism.

[2]  P. Janson,et al.  In vitro production of cyclic AMP and steroids from an ovarian Sertoli‐Leydig cell tumor , 1995, Acta obstetricia et gynecologica Scandinavica.

[3]  B. Wajchenberg,et al.  Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty. , 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  V. Wynn,et al.  The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist , 1988, Journal of endocrinological investigation.

[5]  L. Kennedy,et al.  Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor. , 1987, The Journal of clinical endocrinology and metabolism.

[6]  R. Nieberg,et al.  Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist. , 1986, American journal of obstetrics and gynecology.

[7]  D. Chapin,et al.  The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary. , 1984, The Journal of clinical endocrinology and metabolism.

[8]  E. Wallach,et al.  Clinical uses of luteinizing hormone-releasing hormone. , 1983, Fertility and sterility.

[9]  S. Lamberts,et al.  Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist. , 1982, The Journal of clinical endocrinology and metabolism.

[10]  S. C. Yen,et al.  REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME , 1980 .

[11]  G. Abraham.  Radioimmunoassay of steroids in biological materials. , 1974 .